Combination chemotherapy versus single-agent therapy as first and second-line treatments in metastatic breast cancer: A prospective randomized trial

Joensuu, H et al
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001

Translation for this article does not exist